Cell IDX
San Diego, US · California corporation · 1 known investors
Founders & leadership
DS
David SchwartzExecutive
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 of 2 rounds · 2020
▶$1.3MraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
▶$1.3MraisedDec 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchwartzExecutive Officer
- Offering amount
- $1.7M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Sep 2020
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
▶$451.4KofferedAug 2020 · BiotechnologyRule 506(b)
▶$451.4KofferedAug 2020 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchwartzExecutive Officer
- Offering amount
- $451.4K
- Incorporated
- Corporation, California
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.3M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Cell IDX's investors?
- Cell IDX's investors include Formation Venture Engineering.
- How much funding has Cell IDX raised?
- Cell IDX has disclosed $1.3M raised across 1 of its 2 known rounds.
- Where is Cell IDX headquartered?
- Cell IDX is headquartered in San Diego, US.